Vanda Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-8.1M | $-9.5M | $1.4M | $8.5M |
| FY2017 | $-2.0M | $-3.6M | $1.7M | $10.5M |
| FY2018 | $30.0M | $29.6M | $368.0K | $11.7M |
| FY2019 | $45.9M | $44.9M | $1.0M | $13.5M |
| FY2020 | $51.8M | $50.0M | $1.8M | $13.4M |
| FY2021 | $64.2M | $63.7M | $552.0K | $15.4M |
| FY2022 | $32.0M | $31.3M | $679.0K | $16.3M |
| FY2023 | $12.8M | $12.4M | $383.0K | $14.0M |
| FY2024 | $-15.8M | $-16.2M | $490.0K | $12.4M |
| FY2025 | $-109.4M | $-110.4M | $998.0K | $9.5M |